Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

36th Annual Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

30
November 2015

Join us for the 36th Annual Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT) taking place 9-11 December 2015 in Tokyo, Japan.

View Articles

2015 ACCP Annual Meeting

1
September 2015

'- San Francisco, CA, 27-29 September

View Articles

High Court rules that Health Research Authority acted unlawfully over trial transparency

11
August 2015

<p></p>

View Articles

6th AGAH Dermatological Product Development Workshop Highlights

15
July 2015

As a contributing sponsor Richmond Pharmacology recently attended the 6th AGAH Dermatological Product Development Workshop held June 23-24, 2015, in London, UK.

View Articles

Local volunteers play valuable role in developing new medicines in Croydon

21
March 2014

View Articles

Richmond Pharmacology presents latest Thorough QT study at the ASCPT 2014 Annual Meeting

3
March 2014

View Articles

Latest news

Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology

December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event